We observed enhanced levels of ubiquitinated ATP1A1 in LAPTM4B-depleted PC9 cells (Fig. 5C) and HCC827 cells (Supplementary Fig. S7H), indicating that LAPTM4B may suppress the polyubiquitination of ATP1A1 in NSCLC cells. This evidence concerns the gene ATP1A1 and non-small cell lung carcinoma.